Please note that the details of this Challenge are no longer open. This challenge is awarded and is no longer accepting new submissions. You can:
Challenge Lupus Drug Development
Lupus Drug Development
STATUS: Awarded
Active Solvers: 248
Posted: May 20 2009
Challenge ID: 8321563
 
Share Challenge Share
Abstract
The Seeker is looking for a comprehensive review of the history of Lupus drug development along with actionable recommendations on how this process could be improved. This is a Theoretical Challenge that requires only a written proposal to be submitted.
Overview
The Seeker is looking for a comprehensive review of the history of Lupus drug development – with an emphasis on the past clinical trials – along with actionable recommendations on how this process could be improved. Additional requirements to successful solutions will be presented in the Detailed Description of the challenge.

This is a theoretical challenge that requires only a written proposal to be submitted. The challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker. The Seeker is not looking for a literature review.
What is InnoCentive?
InnoCentive is the global innovation marketplace where creative minds solve some of the world's most important problems for cash awards up to $1 million. Commercial, governmental and humanitarian organizations engage with InnoCentive to solve problems that can impact humankind in areas ranging from the environment to medical advancements.

What is a Theoretical-Licensing Challenge?

An InnoCentive Theoretical Challenge builds upon an idea but is not yet a proof of concept. A solution to a Theoretical Challenge will solidify the Solver's concept with detailed descriptions, specifications and requirements necessary to bringing a good idea closer to becoming an actual product or service.

This Challenge is a Theoretical-Licensing Challenge, meaning that the Seeker is requesting non-exclusive rights to use the winning solution. By contrast, Theoretical-IP Transfer means that Solvers must relinquish all rights to the Intellectual Property (IP) for which they are awarded. For these forms of a Theoretical Challenge, Solvers that do not win retain the rights to their solution after the evaluation period is complete. The Seeker retains no rights to any IP not awarded.

Share This Challenge
InnoCentive Trust Partners